159 related articles for article (PubMed ID: 34790580)
1. Restoring
Pan W; Wang K; Li J; Li H; Cai Y; Zhang M; Wang A; Wu Y; Gao W; Weng W
Front Oncol; 2021; 11():771528. PubMed ID: 34790580
[TBL] [Abstract][Full Text] [Related]
2. Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis.
Wang L; Chen S; Xue M; Zhong J; Wang X; Gan L; Lam EK; Liu X; Zhang J; Zhou T; Yu J; Jin H; Si J
Mol Med; 2012 May; 18(1):389-400. PubMed ID: 22160393
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway.
Yuan YH; Wang HY; Lai Y; Zhong W; Liang WL; Yan FD; Yu Z; Chen JK; Lin Y
Cell Commun Signal; 2019 Jan; 17(1):9. PubMed ID: 30683109
[TBL] [Abstract][Full Text] [Related]
4. miR-10b promotes invasion by targeting HOXD10 in colorectal cancer.
Wang Y; Li Z; Zhao X; Zuo X; Peng Z
Oncol Lett; 2016 Jul; 12(1):488-494. PubMed ID: 27347170
[TBL] [Abstract][Full Text] [Related]
5. Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma.
Guo Y; Peng Y; Gao D; Zhang M; Yang W; Linghu E; Herman JG; Fuks F; Dong G; Guo M
Clin Epigenetics; 2017; 9():116. PubMed ID: 29075359
[TBL] [Abstract][Full Text] [Related]
6. Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation.
Cao YM; Gu J; Zhang YS; Wei WJ; Qu N; Wen D; Liao T; Shi RL; Zhang L; Ji QH; Wang Y; Sun GH; Zhao YX; Wang YJ; Yu J; Zhu YX
Oncol Rep; 2018 Jan; 39(1):338-348. PubMed ID: 29115628
[TBL] [Abstract][Full Text] [Related]
7. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
[TBL] [Abstract][Full Text] [Related]
8. miR-224 enhances invasion and metastasis by targeting HOXD10 in non-small cell lung cancer cells.
Li S; Zhang J; Zhao Y; Wang F; Chen Y; Fei X
Oncol Lett; 2018 May; 15(5):7069-7075. PubMed ID: 29731873
[TBL] [Abstract][Full Text] [Related]
9. IGFBP3, a transcriptional target of homeobox D10, is correlated with the prognosis of gastric cancer.
Xue M; Fang Y; Sun G; Zhuo W; Zhong J; Qian C; Wang L; Wang L; Si J; Chen S
PLoS One; 2013; 8(12):e81423. PubMed ID: 24386080
[TBL] [Abstract][Full Text] [Related]
10. Chemoresistance of colorectal cancer to 5-fluorouracil is associated with silencing of the BNIP3 gene through aberrant methylation.
He J; Pei L; Jiang H; Yang W; Chen J; Liang H
J Cancer; 2017; 8(7):1187-1196. PubMed ID: 28607593
[No Abstract] [Full Text] [Related]
11. SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.
Cheetham S; Tang MJ; Mesak F; Kennecke H; Owen D; Tai IT
Br J Cancer; 2008 Jun; 98(11):1810-9. PubMed ID: 18458674
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of TCF21 by hypermethylation induces cell proliferation, migration and invasion in colorectal cancer.
Dai Y; Duan H; Duan C; Zhou R; He Y; Tu Q; Shen L
Biochem Biophys Res Commun; 2016 Jan; 469(3):430-6. PubMed ID: 26435499
[TBL] [Abstract][Full Text] [Related]
13. miR-501 promotes hemangioma progression by targeting
Zeng Z; Liu S; Cai J; Li Z; Wu H; Chen H; Huang Y
Am J Transl Res; 2019; 11(4):2439-2446. PubMed ID: 31105850
[TBL] [Abstract][Full Text] [Related]
14. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines.
Arnold CN; Goel A; Boland CR
Int J Cancer; 2003 Aug; 106(1):66-73. PubMed ID: 12794758
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through HMGA2 signaling.
Wu H; Zou Q; He H; Liang Y; Lei M; Zhou Q; Fan D; Shen L
Cancer Med; 2019 May; 8(5):2484-2495. PubMed ID: 30938104
[TBL] [Abstract][Full Text] [Related]
16. The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC).
Hakami F; Darda L; Stafford P; Woll P; Lambert DW; Hunter KD
Br J Cancer; 2014 Aug; 111(4):807-16. PubMed ID: 25010866
[TBL] [Abstract][Full Text] [Related]
17. KISS1 methylation and expression as predictors of disease progression in colorectal cancer patients.
Chen SQ; Chen ZH; Lin SY; Dai QB; Fu LX; Chen RQ
World J Gastroenterol; 2014 Aug; 20(29):10071-81. PubMed ID: 25110434
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-10b promotes migration and invasion through Hoxd10 in human gastric cancer.
Wang YY; Li L; Ye ZY; Zhao ZS; Yan ZL
World J Surg Oncol; 2015 Aug; 13():259. PubMed ID: 26311318
[TBL] [Abstract][Full Text] [Related]
19. MiR-106a-5p promotes 5-FU resistance and the metastasis of colorectal cancer by targeting TGFβR2.
Liu J; Huang Y; Wang H; Wu D
Int J Clin Exp Pathol; 2018; 11(12):5622-5634. PubMed ID: 31949649
[TBL] [Abstract][Full Text] [Related]
20. Exosome-Mediated Transfer of circ_0000338 Enhances 5-Fluorouracil Resistance in Colorectal Cancer through Regulating MicroRNA 217 (miR-217) and miR-485-3p.
Zhao K; Cheng X; Ye Z; Li Y; Peng W; Wu Y; Xing C
Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33722958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
